Alignment Healthcare/$ALHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alignment Healthcare
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Ticker
$ALHC
Sector
Primary listing
Employees
1,679
Headquarters
Website
ALHC Metrics
BasicAdvanced
$3.2B
-
-$0.27
1.17
-
Price and volume
Market cap
$3.2B
Beta
1.17
52-week high
$21.06
52-week low
$9.15
Average daily volume
3.6M
Financial strength
Current ratio
1.662
Quick ratio
1.486
Long term debt to equity
233.853
Total debt to equity
233.853
Interest coverage (TTM)
-1.02%
Profitability
EBITDA (TTM)
7.866
Gross margin (TTM)
12.11%
Net profit margin (TTM)
-1.53%
Operating margin (TTM)
-0.62%
Effective tax rate (TTM)
-6.77%
Revenue per employee (TTM)
$1,990,000
Management effectiveness
Return on assets (TTM)
-1.51%
Return on equity (TTM)
-38.53%
Valuation
Price to revenue (TTM)
0.932
Price to book
22.52
Price to tangible book (TTM)
30.43
Price to free cash flow (TTM)
109.439
Free cash flow yield (TTM)
0.91%
Free cash flow per share (TTM)
0.147
Growth
Revenue change (TTM)
49.46%
Earnings per share change (TTM)
-67.01%
3-year revenue growth (CAGR)
36.78%
3-year earnings per share growth (CAGR)
-31.09%
What the Analysts think about ALHC
Analyst ratings (Buy, Hold, Sell) for Alignment Healthcare stock.
Bulls say / Bears say
Q2 total revenue climbed 49% year-over-year to $1.015 billion, beating analyst forecasts and prompting management to raise full-year revenue guidance to between $3.885 billion and $3.910 billion (Reuters)
Health plan membership increased 27.8% year-over-year to about 223,700 members, reflecting strong direct-to-consumer enrollment momentum and prompting the company to upgrade its full-year membership outlook (Reuters)
Alignment achieved Q2 net income of $15.65 million and adjusted EBITDA of $45.91 million, marking its first profitable quarter on a GAAP basis and showing progress toward sustained profitability (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
ALHC Financial Performance
Revenues and expenses
ALHC Earnings Performance
Company profitability
ALHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alignment Healthcare stock?
Alignment Healthcare (ALHC) has a market cap of $3.2B as of September 15, 2025.
What is the P/E ratio for Alignment Healthcare stock?
The price to earnings (P/E) ratio for Alignment Healthcare (ALHC) stock is 0 as of September 15, 2025.
Does Alignment Healthcare stock pay dividends?
No, Alignment Healthcare (ALHC) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Alignment Healthcare dividend payment date?
Alignment Healthcare (ALHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Alignment Healthcare?
Alignment Healthcare (ALHC) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.